Evidence map›Paper›PMID 42619961›Full record

ArticlebioRxiv : the preprint server for biology2026

Human SRP Subunits Coordinate Protein Targeting and mRNA Quality Control.

Morgana K Kellogg, Elena B Tikhonova, Paul F D'Cunha, Andrey L Karamyshev

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Morgana K KelloggDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0003-2286-235X
Elena B TikhonovaDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0002-7892-9173
Paul F D'CunhaDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
Andrey L KaramyshevDepartment of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.ORCID 0000-0001-9645-1655

Funding

Regulation of Aberrant Protein ProductionR01GM135167 · NIGMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI KARAMYSHEV, ANDREY L · 2019 to 2022
$1.3M
NIGMS NIH HHS R01 GM135167
6 · The paper itself

Abstract

The Signal Recognition Particle (SRP) targets secretory proteins to the endoplasmic reticulum (ER) for their subsequent transport and protects their mRNAs from degradation by the RAPP pathway. The SRP is an RNA-protein complex consisting of six protein subunits and one noncoding RNA assembled into S- and Alu-domains. However, the distinct roles of individual SRP subunits remain undetermined. Using a molecular dissection of the human SRP through the depletion of specific subunits, we demonstrate that S-domain subunits have a primary role in mRNA protection and protein targeting, while Alu-domain subunits are dispensable. The SRP54 subunit is essential for both processes and ribosome association, while other S-domain subunits (SRP19, SRP68, and SRP72) serve supportive roles. The expression of SRP subunits is dependent on each other within the same domains, suggesting independent domain assembly. These data provide new insights into the multidomain organization and distinct functions of human SRP subunits and establish a framework for understanding the molecular mechanisms of SRP-related human diseases.

Indexed as

protein quality controlprotein synthesisprotein transportribosomesecreted proteinssignal recognition particle (SRP)

Identifiers

PMID42619961
PMCPMC13484585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.